01—Abstract
Summary
Summary of the 10-Q filed November 8, 2010. Cited figures are marked; the original filing is the authoritative source.
Axon Enterprise, Inc. (AXON) reported a decrease in net sales for both the three-month and nine-month periods ending September 30, 2010, compared to the same periods in the prior year.
The primary drivers for this decline were fewer individually significant international and federal orders, as well as constrained municipal spending due to challenging economic conditions. While overall sales decreased, the company is focusing on new product development, including its EVIDENCE.com platform, which is beginning to contribute to revenue. Despite the sales dip, the company has implemented cost-saving measures, leading to a reduction in Selling, General, and Administrative (SG&A) expenses.
The company's gross margin also experienced a decline, impacted by a shift in product mix, increased costs associated with the EVIDENCE.com service, and higher indirect manufacturing expenses. Research and development expenses were significantly reduced, reflecting the completion of intensive development for certain new products in the prior year. Axon continues to maintain a strong balance sheet with ample cash and cash equivalents, and has access to a revolving credit facility, providing sufficient liquidity for its operations and strategic initiatives.
02—Key points
Key Highlights
- Net sales decreased by 9.6% for the third quarter of 2010 ($21.1M vs. $23.3M in 2009) and 8.2% for the first nine months of 2010 ($64.0M vs. $69.7M in 2009).
- Gross margin declined significantly, with the third quarter margin falling to 49.4% from 56.9% in the prior year, impacted by increased cost of products sold.
- Selling, General, and Administrative (SG&A) expenses were reduced by 17.2% in the third quarter and 11.7% for the first nine months, reflecting cost containment efforts.
- Research and Development (R&D) expenses saw a substantial decrease of 74.7% for the third quarter and 41.7% for the first nine months, due to the completion of major development projects.
- Net loss improved in the third quarter to $2.3 million (from $3.2 million in 2009) and slightly decreased for the first nine months to $4.2 million (from $4.4 million in 2009).
- Cash and cash equivalents decreased by $5.2 million from year-end 2009 to $40.3 million as of September 30, 2010, with net cash used in operating activities for the nine-month period.
- The company has no outstanding debt and maintains a revolving line of credit, indicating strong liquidity and capital resources.
03—One dollar
Follow one dollar
For each $1.00 of revenue in Q3 FY2010, Axon Enterprise, Inc. lost $0.11.
- Revenue$21.1M100.0%
- Cost of revenue−$10.7M50.6%
- Gross profit$10.4M49.4%
- Operating costs−$11.1M52.8%
- Operating income−$724,7333.4%
- Interest, other & tax−$1.6M7.6%
- Net income−$2.3M11.1%
04—Financials
Financial Highlights
Figures from 10-QQ3 FY2010filed November 8, 2010Financial Statements
| Revenue | $21.08M |
| Cost of Revenue | $10.67M |
| Gross Profit | $10.42M |
| R&D Expenses | $1.69M |
| SG&A Expenses | $9.42M |
| Operating Income | -$725K |
| Net Income | -$2.34M |
| EPS (Basic) | $-0.04 |
| EPS (Diluted) | $-0.04 |
| Shares Outstanding (Basic) | 62.34M |
| Shares Outstanding (Diluted) | 62.34M |
05—Questions
Frequently Asked Questions
What is the primary reason for the decline in net sales?
The primary reasons for the decline in net sales for the three and nine months ended September 30, 2010, were fewer individually significant orders from international and federal customers, and generally constrained municipal spending in the U.S. due to challenging economic conditions. The prior year also benefited from larger orders that did not recur in the current periods.
How has the company managed its expenses in light of declining sales?
Axon has implemented cost-saving measures, leading to a significant reduction in Sales, General, and Administrative (SG&A) expenses. This includes decreases in salaries, benefits, bonus, sales and marketing costs, travel expenses, and consulting fees. Research and Development expenses were also substantially reduced, reflecting the completion of development cycles for new products.
What is the company's current liquidity and capital position?
As of September 30, 2010, Axon held $40.3 million in cash and cash equivalents. While net cash from operations was negative for the nine-month period, the company has no outstanding debt and maintains a $10.0 million revolving line of credit, of which $4.8 million was available. The company believes its liquidity is sufficient to finance operations and strategic initiatives.
What new revenue streams or products is the company focusing on?
The company is investing in and developing new integrated hardware and software solutions like the EVIDENCE.com platform, which aims to provide law enforcement agencies with capabilities to capture, store, manage, and analyze video and other digital evidence. While still nascent, these new products, including AXON/EVIDENCE.com and XREP, are beginning to contribute to sales.
06—Continue